Bentham Science Logo

Most Accessed Articles

Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86-105.

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*

DOI: 10.2174/1574892812666171108124218

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*

DOI: 10.2174/1574892812666171129141211

PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145-158.

Kristin N. Taylor and Ramez N. Eskander*

DOI: 10.2174/1574892813666171204094822

Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments

, 2018; 13(4): 455-468.

Weidong Li and Xueying Sun*

DOI: 10.2174/1574892813666180831102519

PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392-410.

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*

DOI: 10.2174/1574892813666180305165256

Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature

, 2018; 13(1): 40-69.

Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves

DOI: 10.2174/1574892812666171108115959

Webmaster Contact:
Copyright © 2018 Bentham Science